Skip to content

Research Articles

Latest articles, insights, and updates from the blog.

181 articles

Contact Low Dose Ketamine

Send corrections, provider questions, or advertising inquiries.

Research1 min read

BDNF Signaling and Ketamine's Antidepressant Action

A detailed examination of how ketamine activates brain-derived neurotrophic factor signaling, TrkB receptor pathways, and the mTOR cascade to produce rapid antidepressant effects. Covers molecular mechanisms, clinical evidence, and implications for personalized treatment.

Research1 min read

Neuroplasticity Mechanisms in Ketamine Therapy

An in-depth exploration of how low-dose ketamine promotes neural rewiring, synaptogenesis, and dendritic spine formation. This article examines the molecular and cellular pathways through which ketamine restores synaptic connectivity in mood and pain disorders.

Research1 min read

Ketamine-Opioid System Interactions: Naltrexone Studies and Debate

How ketamine interacts with opioid receptors, what the naltrexone blockade study found, and what it means for patients on opioid medications.

Research1 min read

Ketamine and the Default Mode Network: Neuroimaging Evidence

How does ketamine affect the brain's default mode network? A review of fMRI, MEG, and PET studies on DMN connectivity, depression, and treatment response.

Research1 min read

Low-Dose Ketamine for Acute Suicidal Ideation: Clinical Evidence

A review of the clinical trial evidence examining low-dose ketamine as an intervention for acute suicidal ideation. This article evaluates randomized controlled trials, naturalistic studies, and emergency department protocols demonstrating ketamine's rapid anti-suicidal effects.

Research1 min read

Ketamine, Neuroplasticity, and Brain-Derived Neurotrophic Factor

How does low-dose ketamine drive neuroplasticity? A look at BDNF release, TrkB and mTOR activation, and the synapse rebuilding behind its rapid antidepressant effect.

Research1 min read

Meta-Analyses of Low-Dose Ketamine for Treatment-Resistant Depression

Meta-analyses of low-dose ketamine for treatment-resistant depression show large 24-hour effects and better durability for racemic ketamine than esketamine.

Research1 min read

Rapid-Onset Antidepressant Mechanisms of Low-Dose Ketamine

Low-dose ketamine's rapid-onset antidepressant mechanisms explain why relief begins in hours, not weeks, via NMDA blockade and BDNF-driven synaptic growth.